Exploring the origin of low back pain sub-classification: a scoping review protocol

Jess, Mary-Anne; Hamilton, Sharon; Ryan, Cormac; Wellburn, Shaun; Martin, Denis

doi:10.11124/jbisrir-2017-003805

Cited by 7 publications

(4 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This scoping review follows an a priori protocol 19 . The JBI methodology for scoping reviews was followed 20 …”

Section: Methodsmentioning

confidence: 99%

“…In the scoping review protocol, 19 it was proposed that the results would be described in a chronological narrative synthesis; instead they have been aggregated into four themes based on the origin of classification of duration for acute, subacute, and chronic pain, which gives a clearer picture of the findings and was a better fit with the aims of the review.…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Exploring the origin of pain subclassification, with emphasis on low back pain: a scoping review

Jess

Hamilton

Ryan

et al. 2020

JBI Evidence Synthesis

Self Cite

View full text Add to dashboard Cite

Objective:This scoping review aimed to explore the different working definitions for the duration of acute, subacute, and chronic pain, with emphasis on low back pain, and to establish where these definitions originated and the rationale provided for the time frames used.Introduction:From a global perspective, low back pain is a major social and economic problem. One of the most commonly used methods to stratify and manage low back pain is the traditional duration-based classification (acute, subacute, and chronic). Where these time points lie to differentiate these transitions continues to be debated within the scientific community, which may engender a degree of heterogeneity in study findings. Therefore, applying these findings to clinical practice may be somewhat challenging. This review encapsulates the historical origins of the different duration categories to provide an understanding of how these variations were derived.Inclusion criteria:Studies that included participants with low back pain were the focus of this review. Sources that included children or other specific pain pathologies, such as cancer pain, were excluded. The main concept of interest was that the publication proposed an original definition of the duration of acute, subacute, or chronic low back pain. All study designs were included provided they gave a rationale for the duration that they used.Methods:The following databases were searched: MEDLINE, Embase, CINAHL, and PsycINFO, from the inception of each database until September 18, 2019. This review was limited to studies published in English. Two independent reviewers screened the retrieved articles against the eligibility criteria. Additional studies were searched from the reference lists of studies to find the original source. Some original sources overlapped with general pain duration literature. This led to a deviation from the scoping review protocol, which originally intended to focus on definitions of low back pain duration only. Data extraction was undertaken using a charting table developed specifically for the review objectives. The findings were presented using narrative synthesis.Results:Nineteen records were included in this review, and comprised three book chapters, four review articles, four articles that arose following pain expert group discussions, seven primary research studies, and a spinal guideline. Data were extracted from the included studies and categorized into four themes based on the origin of the classification of the duration. The themes included i) work/employment setting, ii) empirical studies, iii) expert reasoning, and iv) pathophysiological explanation.Conclusions:This scoping review compiled the existing literature on the working definitions of the duration of acute, subacute, and chronic low back pain and found a wide variation. These ranged from seven days, 14 days, and seven weeks for the acute and subacute transition points, and seven weeks to three years for chronic low back pain. The duration definitions specifically referring to the gene...

show abstract

“…This scoping review follows an a priori protocol 19 . The JBI methodology for scoping reviews was followed 20 …”

Section: Methodsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Exploring the origin of pain subclassification, with emphasis on low back pain: a scoping review

Jess

Hamilton

Ryan

et al. 2020

JBI Evidence Synthesis

Self Cite

View full text Add to dashboard Cite

show abstract

“…Low back pain (LBP) is one of the most common musculoskeletal disorders and cause of disability worldwide; it is estimated that a percentage of patients ranging from 5-10% develops chronic low back pain (CLBP) (Wu et al 2020;Jess et al 2019). Patients with CLBP complain of persisting or recurring pain, muscle stiffness and functional limitation that affect the quality of life.…”

Section: Introductionmentioning

confidence: 99%

Efficacy of balneotherapy on pain, function, and sleep quality in patients with chronic low-back pain: a prospective observational study

Manica,

Claudatus,

Pertile

et al. 2024

Int J Biometeorol

View full text Add to dashboard Cite

The aim of this prospective observational study was to evaluate the e cacy of a cycle of sulphatearsenical-ferruginous mud-bath therapy on pain, function and sleep quality in patients with Chronic Low Back Pain (CLBP). One hundred twenty three patients treated at Levico Spa Center (Italy) with 12 daily local mud packs and generalized thermal baths, were included in this experience. General medical assessments were performed before starting the therapy, at the end of the treatment and three months later. Pain intensity and stiffness were measured by a 0 to 10 cm Visual Analogue Scale (VAS), the range of mobility of the lumbar spine was evaluated using the Schober test and functional disability by the Roland-Morris Disability Questionnaire (RMDI). The Pittsburgh Sleep Quality Index (PSQI) was used to assess the sleep quality. The VAS score for pain and stiffness showed a signi cant reduction (p<0.0001) at the end of the treatment persisting for 3 months of follow-up. Similarly, a signi cant improvement was found for the Schober test and RMDQ. Finally, we showed a signi cant decrease of PSQI score at the end of the cycle of mud-bath and at 3 months of follow-up. The Spearman analysis showed a signi cant positive correlation between the score of PSQI and VAS pain, VAS stiffness and RMDQ. In conclusion, this preliminary study con rms the bene cial and longterm e cacy of balneotherapy on pain and function and, for the rst one, shows the positive effect on quality of sleep in patients with CLBP treated with a cycle of mud-bath therapy.

show abstract

“…In the United States, 25% of patients interviewed regarding common causes of pain reported having suffered from LBP in the 3 months before receiving the questionnaire 5 . LBP is defined as acute when symptoms last 2–12 weeks, 6,7 but up to 60% of patients will develop chronic LBP 8,9 . As first episodes are often self‐resolving, most patients do not seek medical attention, 10 and the lack of adequate care might be one of the causes of the high recurrence rate.…”

Section: Introductionmentioning

confidence: 99%

Nonopioid pharmacological management of acute low back pain: A level I of evidence systematic review

Baroncini

Maffulli

Al-Zyoud

et al. 2023

Journal Orthopaedic Research

View full text Add to dashboard Cite

Acute low back pain (LBP) imposes a significant socioeconomical burden as it is the condition that, worldwide, cause the most disability. Nonetheless, the literature regarding the best pharmacological management of acute LBP is limited, and the indications available in the literature are conflicting. This work investigates whether the pharmacological management of acute LBP can effectively reduce pain and disability, and aims to identify which drugs show the highest efficacy. This systematic review was conducted according to the 2020 PRISMA statement. In September 2022, PubMed, Scopus, and Web of Science were accessed. All the randomized controlled trials investigating the efficacy of myorelaxants, nonsteroidal anti-inflammatory drugs (NSAIDs), and paracetamol for acute LPB were accessed. Only studies that investigated the lumbar spine were included. Only studies reporting on patients with acute LBP with symptom duration of less than 12 weeks were included. Only patients older than 18 years and with nonspecific low back pain were included. Studies that investigated the use of opioids in acute LBP were not considered. Data from 18 studies and 3478 patients were available. Myorelaxants and NSAIDs were effective in reducing pain and disability in acute LBP at approximately one week. The combination of NSAIDs and paracetamol was associated with a greater improvement than the use of NSAIDs alone, but paracetamol alone did not induce any significant improvement. Placebo was not effective in reducing pain. Clinical Significance: Myorelaxants, NSAIDs, and NSAIDs with paracetamol could reduce pain and disability in patients with acute LBP.acute, low back pain, lumbago, management | INTRODUCTIONLow back pain (LBP) is the musculoskeletal condition that causes the most disability worldwide. 1 The rate of first-ever episodes reaches 15%, with 80% of subjects experiencing an activity-imitating recurrence within 1 year. [2][3][4] In the United States, 25% of patients interviewed regarding common causes of pain reported having suffered from LBP in the 3 months before receiving the questionnaire. 5 LBP is defined as acute when symptoms last 2-12 weeks, 6,7 but up to 60% of patients will develop chronic LBP. 8,9 As first

show abstract

Exploring the origin of low back pain sub-classification: a scoping review protocol

Cited by 7 publications

References 17 publications

Exploring the origin of pain subclassification, with emphasis on low back pain: a scoping review

Exploring the origin of pain subclassification, with emphasis on low back pain: a scoping review

Efficacy of balneotherapy on pain, function, and sleep quality in patients with chronic low-back pain: a prospective observational study

Nonopioid pharmacological management of acute low back pain: A level I of evidence systematic review

Contact Info

Product

Resources

About